Comparison between Anthem Biosciences IPO and Dorf-Ketal Chemicals IPO.
Anthem Biosciences IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Dorf-Ketal Chemicals IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Anthem Biosciences IPO is up to ₹3,395.00 Cr whereas the issue size of the Dorf-Ketal Chemicals IPO is up to ₹5,000.00 Cr. The final issue price of Anthem Biosciences IPO is ₹570.00 per share and of Dorf-Ketal Chemicals IPO is .
| Anthem Biosciences IPO | Dorf-Ketal Chemicals IPO | |
|---|---|---|
| Face Value | ₹2 per share | ₹5 per share |
| Issue Price (Lower) | ₹540.00 per share | |
| Issue Price (Upper) | ₹570.00 per share | |
| Issue Price (Final) | ₹570.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ₹50.00 per share | |
| Market Lot Size | 26 shares | |
| Fresh Issue Size | 0 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹1,500.00 Cr |
| OFS Issue Size | 5,95,75,319 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹3,395.00 Cr | up to ₹3,500.00 Cr |
| Issue Size Total | 5,95,75,319 shares | 0 shares |
| Issue Size Total (Amount) | up to ₹3,395.00 Cr | up to ₹5,000.00 Cr |
Anthem Biosciences IPO opens on Jul 14, 2025, while Dorf-Ketal Chemicals IPO opens on . The closing date of Anthem Biosciences IPO and Dorf-Ketal Chemicals IPO is Jul 16, 2025, and , respectively.
| Anthem Biosciences IPO | Dorf-Ketal Chemicals IPO | |
|---|---|---|
| Anchor Bid Date | Jul 11, 2025 | |
| Issue Open | Jul 14, 2025 | |
| Issue Close | Jul 16, 2025 | |
| Basis Of Allotment (Tentative) | Jul 17, 2025 | |
| Initiation of Refunds (Tentative) | Jul 18, 2025 | |
| Credit of Share (Tentative) | Jul 18, 2025 | |
| Listing date (Tentative) | Jul 21, 2025 | |
| Anchor Lockin End date 1 | Aug 15, 2025 | |
| Anchor Lockin End date 2 | Oct 14, 2025 |
Anthem Biosciences IPO P/E ratio is 70.62, as compared to Dorf-Ketal Chemicals IPO P/E ratio of .
| Anthem Biosciences IPO | Dorf-Ketal Chemicals IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)Anthem Biosciences Ltd.'s revenue increased by 30% and profit after tax (PAT) rose by 23% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 76.87 | 99.83 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 74.68 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 70.62 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹31867.39 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 20.82% | 9.09% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 26.88% | 6.40% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.05 | 1.01 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹8.07 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 20.82% | 23.53% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Anthem Biosciences IPO Retail Individual Investors (RII) are offered 2,07,95,834 shares while in Dorf-Ketal Chemicals IPO retail investors are offered 2,07,95,834 shares. Qualified Institutional Buyers (QIB) are offered 1,18,83,333 shares in Anthem Biosciences IPO and in Dorf-Ketal Chemicals IPO.
| Anthem Biosciences IPO | Dorf-Ketal Chemicals IPO | |
|---|---|---|
| Anchor Investor Reservation | 1,78,24,999 shares | |
| Market Maker Reservation | 0 shares | |
| QIB | 1,18,83,333 shares | |
| NII | 89,12,500 shares | |
| RII | 2,07,95,834 shares | |
| Employee | 1,58,653 shares | |
| Others | ||
| Total | 5,95,75,319 shares |
Anthem Biosciences IPO subscribed 67.42x in total, whereas Dorf-Ketal Chemicals IPO subscribed .
| Anthem Biosciences IPO | Dorf-Ketal Chemicals IPO | |
|---|---|---|
| QIB (times) | 192.80x | |
| NII (times) | 44.70x | |
| Big NII (times) | 51.66x | |
| Small NII (times) | 30.80x | |
| RII (times) | 5.98x | |
| Employee (times) | 6.99x | |
| Other (times) | ||
| Total (times) | 67.42x |
